Medical Device Craniomaxillofacial Implants Growth | Page 2

REPORT DESCRIPTION
Craniomaxillofacial Implants for Medical Sector Market – Overview
Craniomaxillofacial implants surgery is also carried out to correct abnormalities and deformities caused by
diseases, such as Crouzon’s disease and Apert’s Syndrome. Initially, the emphasis was just on keeping
absolute stability of the bones, without much attention on free movements. However, owing to
advancements in technology and implant materials such as biocompatible titanium implants, resorbable
plates, screws, and bone grafts, have increased the scope for maintaining stability as well as functionality
of the joints, allowing for ease of treatments related to craniomaxillofacial deformities. Furthermore, lack
of other alternatives for facial surgeries is expected to favor the craniomaxillofacial implants market. Birth
defects such as cleft palate and anotia are also treated through craniomaxillofacial surgeries.
Few growth restraining factors are the high costs associated with craniomaxillofacial surgeries and low
availability of skilled surgeons.
The global craniomaxillofacial implant market was valued at US$ 1,907.9 million in 2016 and is expected
to witness a robust CAGR of 6.2% over the forecast period (2017-2025).